Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial

Anesthesiology

Volumn 118, Issue 1, 2013, Pages 40-50

  Rahe Meyer, Niels ^a,b   Solomon, Cristina ^b,c   Hanke, Alexander ^b   Schmidt, Dirk S ^b   Knoerzer, Dietrich ^d   Hochleitner, Gerald ^e   Sørensen, Benny ^f,g,h   Hagl, Christian ^b   Pichlmaier, Maximilian ^b  

^a FRANZISKUS HOSPITAL   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Salzburger Landeskliniken SALK ^*  (Austria)

^d CSL BEHRING GMBH   (Germany)

^e CSL Behring   (Austria)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN CONCENTRATE; PLACEBO;

ADULT; ALGORITHM; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CARDIOPULMONARY BYPASS; CAUTERIZATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PHARMACIST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THORACIC AORTA SURGERY; THROMBOELASTOGRAPHY;

AORTA; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; FEMALE; FIBRINOGEN; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84871544047     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182715d4d     Document Type: Article

References (38)

1. Diaz-Martin A, Escoresca-Ortega AM, Hernandez-Caballero C, Pena M, Adsuar-Gómez A, Herruzo-Aviles A, Hinojosa-Perez R: Considerations regarding major bleeding after car-diac transplantation. Transplant Proc 2010; 42:3204-5
2. Mannucci PM, Levi M: Prevention and treatment of major blood loss. N Engl J Med 2007; 356:2301-11 (Pubitemid 46849160)
3. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, Montori VM, Roback JD: The effect of plasma transfusion on morbidity and mortality: A systematic review and meta-analysis. Transfusion 2010; 50:1370-83
4. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD: Increased mortality, postoperative morbidity and cost after red blood cell transfusion in patients having cardiac surgery Circulation 2007; 116:2544-52 (Pubitemid 350179219)
5. Spiess BD: Platelet transfusions: The science behind safety, risks and appropriate applications. Best Pract Res Clin Anaesthesiol 2010; 24:65-83
6. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA: Finding the optimal concentration range for fbrinogen replacement after severe haemodilution: An in vitro model. Br J Anaesth 2009; 102:793-9
7. Dempfe CE, Kälsch T, Elmas E, Suvajac N, Lücke T, Münch E, Borggrefe M: Impact of fbrinogen concentration in severely ill patients on mechanical properties of whole blood clots. Blood Coagul Fibrinolysis 2008; 19:765-70
8. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, Tanaka KA: The effects of fbrinogen levels on thromboelastometric variables in the presence of thrombocy-topenia. Anesth Analg 2009; 108:751-8
9. Solomon C, Rahe-Meyer N, Sørensen B: Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res 2011; 128:277-82
10. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, Hellstern P, Saggau W: Relationship between factor XIII activity, fbrin-ogen, haemostasis screening tests and postoperative bleed-ing in cardiopulmonary bypass surgery Thromb Haemost 2005; 93:1101-7 (Pubitemid 40823515)
11. Solomon C, Pichlmaier U, Schöchl H, Hagl C, Raymondos K, Scheinichen D, Koppert W, Rahe-Meyer N: Recovery of fbrinogen after administration of fbrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010; 104:555-62
12. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A: Plasma fbrinogen level, bleeding, and trans-fusion after on-pump coronary artery bypass grafting sur-gery: A prospective observational study. Transfusion 2008; 48:2152-8
13. Reinhöfer M, Brauer M, Franke U, Barz D, Marx G, Lösche W: The value of rotation thromboelastometry to moni-tor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008; 19:212-9 (Pubitemid 351498725)
14. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tønnesen E, Ingerslev J, Sørensen B: Fibrinogen substitu-tion improves whole blood clot frmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7:795-802
15. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B: Fibrinogen concentrate substitu-tion therapy in patients with massive haemorrhage and low plasma fbrinogen concentrations. Br J Anaesth 2008; 101:769-73
16. Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A: Prophylactic fbrinogen infusion reduces bleeding after coronary artery bypass surgery A prospective randomised pilot study. Thromb Haemost 2009; 102:137-44
17. Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, Tanaka KA: Bleeding man-agement with fbrinogen concentrate targeting a high-nor-mal plasma fbrinogen level: A pilot study. Br J Anaesth 2009; 102:785-92
18. Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M: Thromboelastometry-guided administration of fbrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoab-dominal aortic aneurysm surgery J Thorac Cardiovasc Surg 2009; 138:694-702
19. Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J: First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A ret-rospective, single-center cohort study. ANESTHESIOLOGY 2011; 115:1179-91
20. Fenger-Eriksen C, Ingerslev J, Sørensen B: Fibrinogen con-centrate-a potential universal hemostatic agent. Expert Opin Biol Ther 2009; 9:1325-33
21. Ketchum L, Hess JR, Hiippala S: Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 2006; 60(6 Suppl):S51-8
22. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C: Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastog-raphy. J Thromb Haemost 2007; 5:289-95 (Pubitemid 46139453)
23. Solomon C, Sørensen B, Hochleitner G, Kashuk J, Ranucci M, Schöchl H: Comparison of whole blood fbrin-based clot tests in thrombelastography and thromboelastometry Anesth Analg 2012; 114:721-30
24. Summary information about blood products and haemostatic agents, Handbook of Transfusion Medicine. 4th edition. Edited by Mc Clelland DBL. Norwich: The Stationery Offce, 2007, pp 7-15
25. Sørensen B, Bevan D: A critical evaluation of cryoprecipi-tate for replacement of fbrinogen. Br J Haematol 2010; 149:834-43
26. Dickneite G, Pragst I, Joch C, Bergman GE: Animal model and clinical evidence indicating low thrombogenic poten-tial of fbrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009; 20:535-40
27. Manco-Johnson MJ, Dimichele D, Castaman G, Fremann S, Knaub S, Kalina U, Peyvandi F, Piseddu G, Mannucci P; Fibrinogen Concentrate Study Group: Pharmacokinetics and safety of fbrinogen concentrate. J Thromb Haemost 2009; 7:2064-9
28. Craig J, Aguiar-Ibanez R, Bhattacharya S, Downie S, Duff S, Kohli H, Nimmo A, Trueman P, Wilson S, Yunni Y: The clini-cal and cost effectiveness of thromboelastography/thrombo-elastometry Health Technol Assess 2008; 11:1-70
29. Fries D, Innerhofer P, Perger P, Gütl M, Heil S, Hofmann N, Kneifel W, Neuner L, Pernerstorfer T, Pfanner G, Schöchl H, Ziegler B, Kölblinger C, Kozek-Langenecker S: [Coagulation management in trauma-related massive bleeding. Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI)]. Anasthesiol Intensivmed Notfallmed Schmerzther 2010; 45:552-61
30. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Stahel PF, Vincent JL, Spahn DR; Task Force for Advanced Bleeding Care in Trauma: Management of bleeding following major trauma: An updated European guideline. Crit Care 2010; 14:R52
31. Larsen OH, Fenger-Eriksen C, Christiansen K, Ingerslev J, Sørensen B: Diagnostic performance and therapeutic conse-quence of thromboelastometry activated by kaolin versus a panel of specifc reagents. ANESTHESIOLOGY 2011; 115:294-302
32. Solomon C, Cadamuro J, Ziegler B, Schöchl H, Varvenne M, Sørensen B, Hochleitner G, Rahe-Meyer N: A comparison of fbrinogen measurement methods with fbrin clot elasticity assessed by thromboelastometry, before and after adminis-tration of fbrinogen concentrate in cardiac surgery patients. Transfusion 2011; 51:1695-706
33. Velik-Salchner C, Haas T, Innerhofer P, Streif W, Nussbaumer W, Klingler A, Klima G, Martinowitz U, Fries D: The effect of fbrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007; 5:1019-25
34. Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H: Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997; 97:775-84 (Pubitemid 27321375)
35. Coppola L, Caserta F, De Lucia D, Guastaferro S, Grassia A, Coppola A, Marfella R, Varricchio M: Blood viscosity and aging. Arch Gerontol Geriatr 2000; 31:35-42
36. Practice Guidelines for Perioperative Blood Transfusion and Adjuvant Therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. ANESTHESIOLOGY 2006; 105:198-208
37. Ciavarella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, Carrico CJ: Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67:365-8 (Pubitemid 18022356)
38. Thomas D, Wee M, Clyburn P, Walker I, Brohi K, Collins P, Doughty H, Isaac J, Mahoney PM, Shewry L; Association of Anaesthetists of Great Britain and Ireland: Blood transfusion and the anaesthetist: Management of massive haemorrhage. Anaesthesia 2010; 65:1153-61